Safety, Tolerability and Pharmacokinetics of ERX-963 in Adults With Myotonic Dystrophy Type 1
Clinical trial NCT03959189 · COMPLETED
Trial details
- NCT number
- NCT03959189
- Sponsor
- Expansion Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-17
- Primary completion
- 2020-03-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.